BridgeBio Pharma ceo salary
Neil Kumar, Chief Executive Officer of BridgeBio Pharma, Inc. (BBIO), received $12,158,626 ($12.2M) in total compensation for FY2023. Stock awards of $6,123,793 were the largest component. Figures come from BridgeBio Pharma, Inc.'s 10-K filed 20 Feb 2025 (accession 0000950170-25-024119).
Reported total from the latest DEF 14A pay table. Source filing (accession 0000950170-25-024119). These figures come from BridgeBio Pharma, Inc.'s 10-K filed 20 Feb 2025 (accession 0000950170-25-024119).
| Component | Amount |
|---|---|
| Salary | $742,000 |
| Bonus | $779,100 |
| Stock awards | $6,123,793 |
| Option awards | $4,499,993 |
| Other | $13,740 |
| Total | $12,158,626 |
Get this data in your app: free API key, 100 credits.
Get a free API keyFAQ
See also: BBIO ticker page